课题基金 / 基金详情

Exploring the molecular interface between the HIF/hypoxia signalling pathway and mitochondria in cancer

Exploring the molecular interface between the HIF/hypoxia signalling pathway and mitochondria in cancer
探索癌症中 HIF/缺氧信号通路与线粒体之间的分子界面
批准号:
MR/K002201/2
负责人:
Margaret Ashcroft
金额:
$27.69万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --

项目摘要

项目成果

Margaret Ashcroft的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Most organisms need oxygen to survive and generate energy efficiently. Mitochondria are essential subcellular compartments, present within all animal cells that consume oxygen and generate chemical energy. When cellular oxygen levels change, an "oxygen-sensor" called HIF-1alpha increases and switches on specific genes in the nucleus. We have discovered a human gene (CHCHD4) that encodes two mitochondrial proteins that interact with HIF-1alpha. Furthermore, we have also found that HIF-1alpha protein localizes with mitochondria in cells. We have previously shown that CHCHD4 proteins are essential for regulating the amount of HIF-1alpha protein available in the cell when cells experience low oxygen levels (hypoxia). This is important, because high levels of HIF-1alpha are associated with several human diseases including heart and kidney disease, stroke and cancer, where hypoxia is a key contributing factor to the pathology and severity of the disease. The role of HIF-1alpha protein localization with mitochondria and binding to CHCHD4 protein is not known. Thus, the proposed work will explore the molecular interface between HIF-1alpha and mitochondria with specific focus on the role of the HIF-alpha:CHCHD4 interaction in regulating mitochondrial function and metabolism in tumour cells. This work will help us identify novel mechanisms for how tumour cells adapt to their hypoxia microenvironment.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
S79 Localised hypoxia enhances neutrophil extravasation and activation in interstitial lung disease
S79 间质性肺疾病中局部缺氧增强中性粒细胞外渗和活化
DOI: 10.1136/thoraxjnl-2017-210983.85
发表时间: 2017
期刊:
影响因子: --
作者: [Khawaja A]
通讯作者: Khawaja A
DOI: 10.3389/fonc.2018.00388
发表时间: 2018
期刊: Frontiers in oncology
影响因子: 4.7
作者: [Briston T, Stephen JM, Thomas LW, Esposito C, Chung YL, Syafruddin SE, Turmaine M, Maddalena LA, Greef B, Szabadkai G, Maxwell PH, Vanharanta S, Ashcroft M]
通讯作者: Ashcroft M
The mitochondrial oxidoreductase CHCHD4 is present in a semi-oxidized state in vivo.
线粒体氧化还原酶 CHCHD4 在体内以半氧化状态存在。
DOI: 10.17863/cam.24511
发表时间: 2018
期刊:
影响因子: --
作者: [Erdogan A]
通讯作者: Erdogan A
DOI: 10.1371/journal.pgen.1006620
发表时间: 2017-03
期刊: PLoS genetics
影响因子: 4.5
作者: [Connor TM, Hoer S, Mallett A, Gale DP, Gomez-Duran A, Posse V, Antrobus R, Moreno P, Sciacovelli M, Frezza C, Duff J, Sheerin NS, Sayer JA, Ashcroft M, Wiesener MS, Hudson G, Gustafsson CM, Chinnery PF, Maxwell PH]
通讯作者: Maxwell PH
Exploring the molecular interface between the HIF/hypoxia signalling pathway and mitochondria in cancer
  • 批准号:
    MR/K002201/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $51.33万
  • 财政年份:
    2013
  • 负责人:
    Margaret Ashcroft
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: